Renato Arruda

Renato Arruda

Auto-generated profile, based on publicly available information

Renato Arruda

Glia Institute, Ribeirão Preto, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Pediatric Neurology
Verified
Journal Article
Closed access
MAMarco Antônio Arruda
Marco Antônio Arruda
RARenato Arruda
Renato Arruda
VGVicenzo Guidetti
Vicenzo Guidetti
MBMarcelo Eduardo Bigal
Marcelo Eduardo Bigal
JLJesus Landeira-Fernandez
Jesus Landeira-Fernandez
LALuis Anunciacao
Luis Anunciacao

12 September 2025 in Cephalalgia
Verified
Journal Article
Open access
MAMarco Antônio Arruda
Marco Antônio Arruda
RARenato Arruda
Renato Arruda
José Aparecido Da SilvaJosé Aparecido Da Silva
José Aparecido Da Silva
Background: The impact of psychiatric comorbidities in children and adolescents with headache disorders can be more comprehensively understood through a biopsychosocial perspective, which examines the dynamic interplay of factors beyond headache attacks. Resilience and executive function emerge within this framework, playing a central role in development psychopathology and other critical domains. Methods: This narrative review aimed to examine the impact of psychiatric comorbidity on migraine and/or high-frequency headaches (HFH) in children and adolescents through a biopsychosocial perspective centered on the role of resilience and executive function (EF), exploring their potential clinical implications. PubMed was searched for English language articles of human participants, from birth to 18 years, published up to 10 April 2025. Results: Clinical and population-based studies suggest that children and adolescents with migraine and/or HFH are at an increased risk of low resilience and EF impairments. Preliminary interaction and multivariate analyses suggest that high vulnerability (the counterpart to resilience) exerts a moderating role in the psychiatric comorbidity of migraine, as well as a mediating effect in the association of HFH with psychiatric symptoms and disorders. Candidate predictors of psychiatric comorbidity in youths with migraine and/or HFH include EF impairment, high vulnerability, female sex, low socioeconomic status, prenatal exposure to tobacco, poor academic performance and headache attacks accompanied by nausea and vomiting. Conclusions: The multidimensional impact of psychiatric comorbidities on children and adolescents with headache disorders is clearly demonstrated by consistent evidence of their adverse effects on headache severity and chronification, as well as negative outcomes in quality of life, cognitive performance, academic achievement and overall patient well-being, leading to long-term continuity across childhood, adolescence and adulthood. Most of this impact is probably due to the interactions between reduced resilience, increased vulnerability and EF impairment. This narrative review underscore the relevance of routinely assessing psychiatric symptoms, resilience, executive function skills and school functioning in children and adolescents with headache disorders. Future studies should examine whether early interventions focused on resilience, vulnerability and EF can prevent psychiatric comorbidities and improve headache outcomes in children and adolescents with migraine and/or HFH.

30 September 2023 in Headache Medicine
Verified
Journal Article
Open access
PDF file
RARenato Arruda
Renato Arruda
MAMarco Antônio Arruda
Marco Antônio Arruda
Introduction
Headaches and migraine are common in the pediatric population, being one of the most frequent symptoms reported in practice. Additionally, it is a considerably disabling condition, which brings significant burden and impairs several aspects of a child or adolescent's life, such as mental and physical health, executive functioning, school performance. Children and adolescents with migraine have higher risk of psychiatric comorbidities and psychosocial adjustment difficulties, which, in turn, compromise even more patient's well-functioning. Objective
The present article provides the clinician with a straightforward and evidence-based approach to migraine treatment in this age group. Comment
Treatment of migraine in children and adolescents requires a systematic and thorough approach. Clinicians should keep in mind the important burden migraine brings to a child's life, thus investigate, and properly manage comorbidities presented. Patient and parents' education is a meaningful part of the treatment. Moreover, non-pharmacological treatments, such as healthy lifestyle habits, behavioral interventions may also play beneficial roles. When preventive treatment is indicated, it should be tailored considering drug's profile of effectiveness and safety, as well as patient's comorbidities. Lack of evidence in this context must not translate in lack of action by the clinician, since there may be a relevant burden associated. Therefore, reasoning for the perspicacious clinician is of fundamental importance and may influence positively the outcomes.

1 November 2022 in Archives of Pediatric Neurosurgery
Verified
Journal Article
Open access
PDF file
LBLuisa Bigal
Luisa Bigal
RARenato Arruda
Renato Arruda
MAMarco Antônio Arruda
Marco Antônio Arruda
MBMarcelo E. Bigal
Marcelo E. Bigal
In predisposed individuals, migraine evolves into a stage of daily or nearly daily headaches, known as chronic migraine. Although relatively prevalent and debilitating at all ages, chronic migraine is particularly aggressive in the pediatric population. Several risk factors for chronic migraine have been identified, largely due to two very large longitudinal studies, the American Migraine Prevalence and Prevention Study (AMPP) and the Attention Brazil Project (ABP). This review summarizes lessons learned from these studies that included children from 5 to 19 years of age. We start by contextualizing chronic migraine and by offering a systematic approach to diagnosis. We then discuss pre-natal and post-natal risk factors for migraine transformation, and close by reviewing treatment strategies, ultimately attempting to offer a meaningful overview of chronic migraine in pre-adults based on our experience conducting these studies.

18 November 2026 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
SFStephen V. V Faraone
Stephen V. V Faraone
APAlison E. Pritchard
Alison E. Pritchard
MBMark A. Bellgrove
Mark A. Bellgrove
JBJan K. Buitelaar
Jan K. Buitelaar
LYLi Yang
Li Yang
SCSamuele Cortese
Samuele Cortese

27 October 2022 in Headache Medicine
Verified
Journal Article
Open access
PDF file
RARenato Arruda
Renato Arruda
CBCarlos Alberto Bordini
Carlos Alberto Bordini
Introduction The headache field, mainly migraine, is passing through a transformative era of new treatments. These breakthroughs would not be possible without the evolving knowledge on mechanisms of headaches. However, there are still unmet needs for headaches' understanding and treatments. Objectives Assess whether there is a trend in the number of publications regarding physiopathology of each primary headache disorders (PHD) in the past 50 years. Secondarily, we aimed to evaluate how the SARS-CoV-2 pandemics impacted on physiopathology research of PHD. Methods PHD were divided hierarchically in first- and second-digit, according to ICHD-3 criteria. PubMed database was searched using both the name of the PHD and MeSH terms related to physiopathology. Each search yielded the number of publications for a determined PHD along the period selected (1971-2021). Data were retrieved and separated in two groups: a) per decades (1971-2020); and b) per year (2011-2021). Ratios between every two timepoints in each group were calculated, as well as a total ratio for the whole interval. Results Either divided per decades, or divided annually for the last 10 years, migraine had the highest absolute number of pathophysiology publications, significantly above the other PHD. Divided per decades, with exception of tension-type headache (TTH), all the other PHD groups have increased their number of publications over time. Meanwhile, TTH in the last decade decreased the total number of mechanisms research. The number of papers published in 2020 was lower than in 2019 for TTH, trigeminal autonomic cephalalgias (TACs) and group 4 "other PHD" (4.OPHD), migraine kept practically the same number. Conclusion There is a clear disparity in the number of publications on mechanisms of each PHD, being migraine well above TTH, TACs and 4.OPHD. As expected, the recent COVID pandemics has clearly impaired pathophysiologic research in the headache field. Keywords: Headache, Migraine, Mechanisms, Physiopathology, Research.